Instant Download
Your unique download link appears right after you complete your purchase, and is also sent instantly to the email address you provided.
Save up to 70% on all courses, discount auto applied
Kidney Disease Clinical Trialists Workshop 9th Edition 2025
Kidney Disease Clinical Trialists Workshop 9th Edition 2025
Regular price
$52.00 USD
Regular price
Sale price
$52.00 USD
Couldn't load pickup availability
Multi Speciality
Multi Speciality
Yes
Primary Speciality
Primary Speciality
Internal-Medicine-Primary-Care
Target Audience
Target Audience
nephrologists, internists
Content Type
Content Type
Video Only
Size
Size
Video Only
Year
Year
Provider/Organization
Provider/Organization
Other
- Include: 4 videos, size: 57.5 GB
- Target Audience: nephrologists, internists
- Sample video: contact me for sample video
- Information:
Embassy of France, Washington DC
The Kidney Disease Clinical Trialists (KDCT) Workshop is a high level think-tank, with an exceptional expert faculty. It involves a limited number of attendees (up to 130) and includes distinguished nephrologists, clinical trialists, principal investigators and statisticians from academia, R&D pharma, patient representatives and device companies, NIH, EMA, PMDA and FDA experts.
The KDCT Workshop aims to foster an international exchange of ideas where we will brainstorm on trial design, conduct, ethics, interpretation, approvability and implementation encompassing drugs, devices, biomarkers and therapeutic strategies for kidney disease.
Our objectives are to produce relevant data from controlled kidney disease clinical trials (beyond cardiovascular outcomes trials) that will contribute to better clinical care and to understand the problems associated with making decisions about what constitutes relevant information, how to improve kidney disease clinical trials, and, as is commonly the case, how to satisfy regulatory authorities and payers.
The 9th Edition of the Kidney Disease Clinical Trialists (KDCT) Workshop 2025 is tailored for a highly specialized group of physicians and researchers involved in kidney disease clinical trials. The core physician audience includes:
Nephrologists
Clinical trialists and principal investigators
Academic researchers in nephrology and internal medicine
Physicians from regulatory bodies (e.g., NIH, EMA, PMDA, FDA)
Medical professionals from R&D in pharma and device companies
This workshop is a high-level think tank with a limited number of attendees (up to 130), designed to foster international collaboration on trial design, ethics, biomarkers, and regulatory strategies for kidney disease interventions.
- Topics:
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
April 4 Initial Track.mp4
April 4 Parallel Track.mp4
April 5 Initial Track.mp4
April 5 Parallel Track.mp4
* Detail:
